Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral …
NR Machado, BO Fagundes, LA Fernandes… - Frontiers in …, 2023 - frontiersin.org
Human T-lymphotropic virus 1 (HTLV-1) infected individuals remain as asymptomatic
carriers (ACs) or can develop the chronic neurological disorder HTLV-1-associated …
carriers (ACs) or can develop the chronic neurological disorder HTLV-1-associated …
Ripasudil as a Potential Therapeutic Agent in Treating Secondary Glaucoma in HTLV-1-Uveitis: An In Vitro Analysis
M Yang, K Kamoi, Y Zong, J Zhang, Y Zou… - International Journal of …, 2024 - mdpi.com
Human T-cell leukemia virus type 1 (HTLV-1), a virus that affects 5–10 million people
globally, causes several diseases, including adult T-cell leukemia-lymphoma and HTLV-1 …
globally, causes several diseases, including adult T-cell leukemia-lymphoma and HTLV-1 …